The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): A randomized controlled trial

Peritoneal Dialysis International

Volumn 31, Issue 4, 2011, Pages 450-458

  Fischbach, Michel ^a   Issad, Belkacem ^b   Dubois, Vincent ^c   Taamma, Redouane ^c  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Fresenius Medical Care Nephrocare France   (France)

Author keywords

Adapted; APD; Bloodpressure; Dialysis efficiency; Dwell time; Fill volume; Glucose sparing; UF efficiency

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATED PERITONEAL DIALYSIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DIALYSATE; DIASTOLIC BLOOD PRESSURE; DWELL TIME; FILL VOLUME; GLUCOSE ABSORPTION; HUMAN; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; OPEN STUDY; PERITONEAL DIALYSIS; PHOSPHATE DIALYTIC REMOVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL SYSTEM PARAMETERS; SODIUM DIALYTIC REMOVAL; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; TIME;

DIALYSIS FLUID;

ADULT; AGED; AGED, 80 AND OVER; CROSS-OVER STUDIES; DIALYSIS SOLUTIONS; HUMANS; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84855175003     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00146     Document Type: Article

References (37)

1. Diaz-Buxo JA. Enhancement of peritoneal dialysis: the PD Plus concept. Am JKidney Dis 1996; 27:92-8.
2. Durand PY, Freida P, Issad B, Chanliau J. How to reach optimal creatinine clearances in automated peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1):S167-70.
3. Fischbach M, Desprez P, Terzic J, Lahlou A, Mengus L, Geisert J. Use of intraperitoneal pressure, ultrafiltration and purification dwell times for individual peritoneal dialysis prescription in children. Clin Nephrol 1996; 46:14-16.
4. Fischbach M, Lalhou A, Eyer D, Desprez P, Geisert J. Determination of individual ultrafiltration time (APEX) and purification phosphate time by peritoneal equilibration test: application to individual peritoneal dialysis modality prescription in children. Perit Dial Int 1996; 16(Suppl 1):S557-60.
5. Wang T, Heimbürger O, Cheng H, Waniewski J, Bergström J, Lindholm B. Effect of increased dialysate fill volume on peritoneal fluid and solute transport. Kidney Int 1997; 52:1068-76.
6. Malhotra D, Murata GH, Tzamaloukas AH. Creatinine clearance and urea clearance in peritoneal dialysis: what to do in case of discrepancy. Perit Dial Int 1997; 17:532-5.
7. Fischbach M, Terzic J, Bergère V, Gaugler C, Provot E. The optimal approach to peritoneal dialysis prescription in children. Perit Dial Int 1999; 19(Suppl 2):S462-6.
8. Fischbach M, Stefanidis CJ, Watson AR on behalf of the European Paediatric Peritoneal Dialysis Working Group. Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription. Nephrol Dial Transplant 2002; 17:380-5.
9. Fischbach M, Terzic J, Menouer S, Bergere V, Ferjani L, Haraldsson B. Impact of fill volume changes on peritoneal dialysis tolerance and effectiveness in children. Adv Perit Dial 2000; 16:321-3.
10. Durand PY. Optimization of fill volumes in automated peritoneal dialysis. Perit Dial Int 2000; 20:601-2.
11. Fischbach M, Terzic J, Menouer S, Haraldsson B. Optimal volume prescription for children on peritoneal dialysis. Perit Dial Int 2000; 20:603-6.
12. Fischbach M, Dheu C, Seugé-Dargnies L, Delobbe JF. Adequacy of peritoneal dialysis in children: consider the membrane for optimal prescription. Perit Dial Int 2007; 27(Suppl 2):S167-70.
13. Dombros N, Dratwa M, Feriani M, Gokal R, Heimbürger O, Krediet R, et al. on behalf of the EBPG Expert Group on Peritoneal Dialysis. European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. Nephrol Dial Transplant 2005; 20(Suppl 9):ix24-7.
14. Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, et al. on behalf of the ISPD Adequacy of Peritoneal Dialysis Working Group. Perit Dial Int 2006; 26:520-2.
15. Fischbach M, Warady BA. Peritoneal dialysis prescription in children: bedside principles for optimal practice. Pediatr Nephrol 2009; 24:1633-42.
16. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. Am Soc Nephrol 1994; 4:1820-6.
17. Fischbach M, Haraldsson B. Dynamic changes of the total pore area available for peritoneal exchange in children. J Am Soc Nephrol 2001; 12:1524-9.
18. Chagnac A, Herskovitz P, Ori Y, Weinstein T, Hirsh J, Katz M, et al. Effect of increased dialysate volume on peritoneal surface area among peritoneal dialysis patients. JAm Soc Nephrol 2002; 13:2554-9.
19. Durand PY, Chanliau J, Gambéroni J, Hestin D, Kessler M. Intraperitoneal hydrostatic pressure and ultrafiltration volume in CAPD. Adv Perit Dial 1993; 9:46-8.
20. Durand PY, Chanliau J, Gambéroni J, Hestin D, Kessler M. Measurement of hydrostatic intraperitoneal pressure: a necessary routine test in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1):S84-7.
21. Fischbach M, Terzic J, Laugel V, Escande B, Dangelser C, Helmstetter A. Measurement of hydrostatic intraperitoneal pressure: a useful tool for the improvement of dialysis dose prescription. Pediatr Nephrol 2003; 18:976-80.
22. Dejardin A, Robert A, Goffin E. Intraperitoneal pressure in PD patients: relationship to intraperitoneal volume, body size and PD-related complications. Nephrol Dial Transplant 2007; 22:1437-44.
23. Fischbach M, Desprez P, Donnars F, Hamel G, Geisert J. Optimization of CCPD prescription in children using peritoneal equilibration test. Adv Perit Dial 1994; 10:307-9.
24. Holmes C, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl 2006; (103):S104-9.
25. Demetriou D, Habicht A, Schillinger M, Hörl WH, Vychytil A. Adequacy of automated peritoneal dialysis with and without manual daytime exchange: a randomized controlled trial. Kidney Int 2006; 70:1649-55.
26. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S5-21.
27. Davies SJ. Preserving residual renal function in peritoneal dialysis: volume or biocompatibility? Nephrol Dial Transplant 2009; 24:2620-2.
28. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. on behalf of the Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
29. Chaudhary K, Khanna R. Biocompatible peritoneal dialysis solutions: do we have one? Clin J Am Soc Nephrol. 2010; 5:723-32.
30. Granja CA, Juergensen P, Finkelstein FO. Phosphate balance in peritoneal dialysis patients: role of ultrafiltration. Contrib Nephrol 2009; 163:198-205.
31. Schmitt CP, Borzych D, Nau B, Wühl E, Zurowska A, Schaefer F. Dialytic phosphate removal: a modifiable measure of dialysis efficacy in automated peritoneal dialysis. Perit Dial Int 2009; 29:465-71.
32. Waniewski J, Dutka V, Stachowska-Pietka J, Cherniha R. Distributed modeling of glucose-induced osmotic flow. Adv Perit Dial 2007; 23:2-6.
33. Verger C, Larpent L, Veniez G. Mathematical determination of PET (Abstract 181). Perit Dial Int 1990; 10(Suppl 1):.
34. Coester AM, Smit W, Struijk DG, Krediet RT. Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function. NDT Plus 2009; 2:104-10.
35. Davies S, Carlsson O, Simonsen O, Johansson AC, Venturoli D, Ledebo I, et al. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant 2009; 24:1609-17.
36. Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, et al. AngiotensinII induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 2001; 142:1489-96.
37. Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, et al. Il-6 and serum amyloidA synergy mediates angiotensinII-induced muscle wasting. JAm Soc Nephrol 2009; 20:604-12.